Trials / Terminated
TerminatedNCT02362880
Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography Study
Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease: 18F-Florbetaben Positron Emission Tomography Study
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Judit Pich Martínez · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of the study is to assess safety of a single dose of FBB followed by PET scan in individuals at risk of genetic Alzheimer's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Florbetaben | single dose of Florbetaben followed by PET scan |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2015-02-13
- Last updated
- 2021-04-14
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02362880. Inclusion in this directory is not an endorsement.